Stockreport

Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment [MSNBC.com]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF RocheFirst-quarter sales came in at 14.7 billion Swiss francs ($18.7 billion), down 5% year-on-year — but up 6% on a constant currency basis.The appreciation of the Swis [Read more]